F.D.A. Grants Early Access to Promising Drug for Pancreatic Cancer

Written by

in

The New York Times – Business:

Patients with one of the deadliest cancers have been pleading for an unapproved treatment that may prolong their lives.

RSS Feed
Author: RSS Feed

This post first appeared in The New York Times – Business. Read the original article.